Johns Hopkins ABX Guide
Adefovir
INDICATIONS
FDA
FDA
- Chronic hepatitis B in patients 12 years of age and older
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 8, 2018
Citation
Smith, Janessa M, and Paul A Pham. "Adefovir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540008/all/Adefovir.
Smith JM, Pham PA. Adefovir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540008/all/Adefovir. Accessed October 3, 2024.
Smith, J. M., & Pham, P. A. (2018). Adefovir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540008/all/Adefovir
Smith JM, Pham PA. Adefovir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2024 October 03]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540008/all/Adefovir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adefovir
ID - 540008
A1 - Smith,Janessa,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2018/07/08/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540008/all/Adefovir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
